Hjem › Steatotisk leversygdom › Washington
Steatotisk leversygdom kliniske forsøg i Washington
7 studier for Steatotisk leversygdom søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Washington Gastroenterology - Bellevue, Bellevue
- UW Medicine Diabetes Institute, Seattle
- Washington Gastroenterology - Tacoma, Tacoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Seattle
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 21. sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Seattle
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT07221188A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- og 1 flere
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Seattle
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 27. jul. 2026 · NCT07221227Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
- University of Washington, Seattle
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 8. dec. 2025 · NCT07270601Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.